TrialCirculation2024

A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.

Kazuya Hosokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.